Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Amebiasis Market?

Recently, the amebiasis market has experienced robust expansion. The market valuation is expected to increase from $0.82 billion in 2024 to $0.88 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.6%. The past growth can be linked to the rising number of amoebic infection cases in tropical locations, deficient sanitation and cleanliness norms in emerging economies, a surge in international travel, particularly to disease-prone areas, increasing consciousness about the ailment, and the absence of clean drinking water in rural settings.

The market for amebiasis is projected to experience significant expansion in the upcoming years. The market is set to rise to $1.13 billion by 2029, expanding at a compound annual growth rate of 6.5%. Factors fuelling this growth during the forecast period include an increase in immune-compromised individuals, escalated government efforts towards improved sanitation and healthcare infrastructure, expanded funding in research for innovative treatment methods, amplified focus on health measures against parasitic diseases, and heightened demand for effective oral drugs. Major forecast period trends incorporate a growing preference for combination therapies, vaccine development efforts, improvements in drug delivery systems, enhancement in pharmaceutical research, and creation of novel antiprotozoal medications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Amebiasis Market?

The rise in parasitic infections is anticipated to drive the expansion of the amebiasis market. Parasitic infections, which are diseases caused by parasites like protozoa, helminths, or ectoparasites that live off their host, have been on the rise due to factors such as increased travel, climatic changes, poor hygiene, and growing drug resistance. These factors play a significant role in the spread and endurance of these infections. The parasite entamoeba histolytica, which leads to amebiasis through invasion of the intestines, results in symptoms like diarrhea, abdominal discomfort, and in severe cases, tissue damage and liver abscesses. For instance, the UK’s Animal and Plant Health Agency reported a total of 1,071 diagnoses of Parasitic Gastroenteritis (PGE) in January 2024, with 190 haemonchosis cases and 95 instances of nematodirosis from 2022. The haemonchosis cases in 2022 showed a notable rise from the previous year. Consequently, the rising trend of parasitic infections is the driving force behind the growth of the amebiasis market.

What Are The Key Segment Trends Observed In The Amebiasis Market?

The amebiasismarket covered in this report is segmented –

1) By Type: Metronidazole; Paromomycin; Tinidazole

2) By Route Of Administration: Oral; Intravenous

3) By Application: Hospital; Pharmacy

Subsegments:

1) By Metronidazole: Oral Metronidazole; Intravenous Metronidazole; Combination Therapy with Metronidazole

2) By Paromomycin: Oral Paromomycin; Paromomycin in Combination with Other Drugs

3) By Tinidazole: Oral Tinidazole; Tinidazole for Severe Infections

Which Long-Term Trends Will Play A Crucial Role In The Amebiasis Market?

Leading organizations involved in the amebiasis market are focusing on creating innovative solutions such as ready-to-use oral liquid metronidazole to enhance patient adherence and treatment effectiveness. The pre-prepared liquid form of the antibiotic metronidazole, used for treating afflictions like amebiasis, simplifies the process for patients who struggle with pill consumption. For instance, the U.S. Food and Drug Administration authorized Kesin Pharma Corporation, a pharmaceutical company based in the U.S., to release Likmez (metronidazole) oral suspension, 500 mg/5 mL, in November 2023. This authorization signifies the first time a ready-to-use oral liquid form of metronidazole has been approved. This form, particularly suitable for children due to its ease of ingestion and precise dosage, ensures adherence to the treatment course. Additionally, the liquid format allows for dosage adjustments by healthcare practitioners, accommodating individual patient requirements and varying degrees of infection severity.

Who Are The Leading Companies Driving The Amebiasis Market?

Major companies operating in the amebiasis market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cepheid Inc., Mission Pharmacal Company, Profounda Inc., Zydus Lifesciences Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report

Which Region Is Forecasted To Lead The Amebiasis Market In The Coming Years?

North America was the largest region in the amebiasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amebiasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21094&type=smp

Browse Through More Reports Similar to the Global Amebiasis Market 2025, By The Business Research Company

Difficile Associated Diarrhea Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/difficile-associated-diarrhea-treatment-global-market-report

Antidiarrheals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidiarrheals-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model